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Al l  living orgamsms have an intricate network of 
systems whose role is to repair damage to DNA. One 
of the most important of these, nucleotide xcision 
repair (NER), is a five-step pathway that eliminates a
variety of structurally unrelated lesions, including UV- 
induced cyclobutane pyrimidine dimers (CPD) and 
(6--4) photoproducts, many types of chemical adducts 
and DNA crosslinks. As summarized in part I of this 
review t, the mechanism of NER is best understood in 
the bacterium E. coli. In part II, I focus on the more 
complex pathway in eukaryotes, about which much 
less is known. I shall discuss the main features and 
biological impact of NER in mammals, and attempt o 
put these into an evolutionary and mechanistic per- 
spective by comparing mammalian NER with the yeast 
system. For a comprehensive r view on DNA repair in 
general, see Ref. 2. 
General characteristics of mammalian NER 
Each mammalian ucleus contains approximately 
two metres of DNA and repair systems face a formidable 
task in surveying this for the presence of lesions. This 
logistic problem seems to be reduced to some extent 
by the preferential (i.e. more rapid and complete) 
repair of transcribed sequences, a process that is car- 
ried out by a special NER subpathway also round in 
E. coli and yeast 3. Apparently, high priority is given 
to rapid resumption of transcription when this vital 
process is blocked by lesions in the template. The 
initial recognition and signalling of DNA injury in 
this subpathway is probably performed by RNA 
polymerase, whereas in the more slow 
and incomplete 'overall genome' NER 
subpathway, lesions are thought to be 
detected by repair complexes scanning 
the DNA. The screening for conforma- 
tional abnormalities by RNA polymerase II 
may be more rigorous and this may 
explain why some lesions, such as CPDs, 
are more efficiently removed from tran- 
scribed strands than from the rest of the 
genome3. Other lesions, such as 6-4 photo- 
products, are already very efficiently rec- 
ognized by the overall genome repair 
system. Their rate of removal from the 
bulk of DNA is almost the same as that 
achieved by transcription-coupled r pair. 
Human NEll-deficient syndromes 
The consequences of deficient excision 
repair are apparent from the clinical 
symptoms of the human repair disorders 
xeroderma pigmentosum (XP), Cockayne's 
syndrome (CS) and PIBIDS, a special form 
of trichothiodystrophy. Patients suffering 
from one of these rare autosomal recess- 
ive diseases are very sensitive to sun (UV) 
light. XP patients how pigmentation ab- 
normalities and numerous premalignant 
lesions in sun-exposed skin, as well as 
a predisposition to skin cancer and, 
often, accelerated neurodegeneration. 
Neurological dysfunction is also a hallmark 
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An intricate network of repair systems safeguards the 
integrity of genetic materla~ by eliminating DNA lesions 
induced by umeroas environmental and endogetmus 
genotoxic agents. Nuelcotide xcision repair (NER) is one 
of the most versatile DNA repair systems. Deficiencies in 
this process give rise to the classY! human DNA repair 
disorders xeroderma p~gmet~sum (XP) and Cockayne's 
syndrome (CS), and to a recent~ recognized disease called 
PIBIDYb a photosensigive form of the brittle hair disorder 
trichothiodystrophy. This is the second of a two-part 
review on NER. Part ! (in the previons issue of TIG) 
conce~'ated on the main characteristics of the NER 
pathway of £ coil and yeast Part H compares the 
mammalian aBd yeast systems, and attempts o integrate 
cur~ knowledge on the eukaryottc pathway to suggest 
an outline for the reaction mechanisnt 
of CS, although the underlying cause, demyelination of
neurons, is different. Growth is retarded in all CS 
patients, and in a subset of XP patients. Remarkably, CS 
patients do not have an elevated incidence of (skin) 
cancer. (For reviews on the clinical features of XP and 
CS, see Refs 4 and 5, respectively.) 
PIBIDS is an acronym for a complex syndrome that 
comprises photosensitivity, ichthyosis (scaling of the 
FIG]I] 
Micrograph showing complementation of the DNA-repair defect in XP. 
Fibroblasts from two XP patients were labelled with latex beads of different 
diameter and fused using activated Sendal virus. Cells were then UV-irradiated 
and subsequently incubated inthe presence of 3HTdR. Unscheduled DNA repair. 
synthesis (UDS) was visualized using in situ autoradiography. Thenumber of 
autoradiographic grains over each nucleus reflects the repair capacity of the cell. 
The nonfused monokaryons (of complementation group C and G) show UDS 
that is greatly reduced (XP-C) or completely absent (XP-G). The heterodikaryon, 
which contains both types of latex beads, has a normal level of UDS. 
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T~ 1. Properties ofXP, CS mad ~ complementatton groups 
caeim femmzs ~ m , - ~  
Relative 
sJda Smmlegica Utquem'yof ~-  ~e~ 
Group ¢ama' abammMl~ eccunmce semiavay UnS, nemarks 
XP-A + ++ high +++ <5 
XP-B +/- +++/+ very rare ++ <10 
XP..C + - high + 15--30 
selective 
XP-D + ++/- intermediate ++ 15-50 
XP/CS 
XP-E +/- - rare + >50 
XP-P +/- - rare/intermediate + 15--30 
XP-G +/- +++/+ rare ++ <10 
XP-V + - high + 100 
CS-A - ++ rare + 100 
normal 
CS-B - ++ high + 100 
normal 
TrD1BR - + very rare + 15 
Different from rodent groups 1-7, 11 
Combined XP/CA 
Identical to rodent group 3 
Deficient in 'global genome' 
repair 
Normal preferential strand- 
selective repair 
Includes patients with PIBIDS 
and patients with XP/CS 
Idet~cal to rodent group 2 
Repair slow but prolonged 
Includes patients with CA 
Defective in post-replication repair 
Normal NER 
Defective in preferential swand- 
selective repair 
'Global genome' repair normal 
Defective in preferential strand- 
selective repair 
'Global genome' repair normal 
Identical to rodent group 6 
PIBIDS 
*Unscheduled DNA synthesis as a imrc, ntage of wild-type activity. 
skin), brittle hair, impaired intelligence, decreased fer- 
tility, and short stature. PIBIDS resembles CS in many 
aspects: its effects on growth, the nervous system 7, 
sexual development and photosensitivity, and in its 
lack of association with cancer. Brittle hair, caused 
by a reduced content of cysteine-rich matrix proteins, 
is the most prominent characteristic of trichothio- 
dystrophy, a disorder that also affects patients who are 
not photosensitive (reviewed in Ref. 6). 
NER deficiency is reflected at the cellular level as 
hypersensitivity to UV and to agents that mimic the 
effect of UV; in most XP and PIBIDS patients, UV- 
induced unscheduled DNA synthesis (UDS) is also 
slower or completely absent 4. The NER defect in classi- 
cal CS is limited to the subpathway of preferential 
repair of (the transcribed strand of) active genes; the 
less efficient 'overall genome' repair system is still 
functional s. Since preferential repair makes a relatively 
small contribution to the total repair synthesis, CS 
fibroblasts show near-normal levels of UDS. However, 
the preferential repair defect prevents the rapid re- 
covery of RNA synthesis after UV exposure and this 
probably causes the increased UV sensitivity. 
Complementation analysis shows that all three NER 
disorders are genetically heterogeneous: fusion of cells 
from different patients can complement each repair 
defect. An example of XP complementation is shown 
in Fig. 1. Seven excision-deficient XP complementation 
groups (designated XP-A to XP-G) have been cata- 
logued to date0 (Table 1). An eighth group, called XP- 
variant, has normal NER but is thought o be impaired 
in the poorly defined postreplication repair pathway 1°, 
Patients who have CS only fall into one of two comp- 
lementation groups 6, CS-A or CS-B, whereas a number 
of very rare individuals with combined manifes- 
tations of XP and CS fall into XP groups B, D and G 
(Ref. 9 and our unpublished results; Table 1). At least 
two complementation groups can be distinguished for 
PIBIDS. Most patients have been assigned to XP group 
D (Ref. 11), further extending the clinical hetero- 
geneity of this form of XP (Ref. 12). One recently 
identified PIBIDS patient constitutes an entirely new 
group t3, The finding that a second NER gene is associ- 
ated with the clinical symptoms of PIBIDS underscores 
the pleiotropic and unexpected clinical effects associ- 
ated with mutations in NER genes, such as the occur- 
rence of sulfur-deficient brittle hair. 
Repair deficiency is most severe in XP groups A, B 
and G, and affects both overall genome and preferen- 
tial repair. In XP-C the excision defect is limited to the 
overall genome pathway 14, thus XP-C is the biochemi- 
cal opposite of CS-A and CS-B. Since the efficiency of 
overall genome repair has a strong impact on muta- 
genesis, this may explain the high incidence of skin 
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TAm~ 2. Properties of rodent NER complementation groups 
Semiflvay of mmant" 
Representative Parental Incision 
Group mutant cellline UV ~ C  deficient 
Correcfl~ XP/CS 
8medoaed 
1 UV20 CHO ++ +++ yes 
43 -3B 
2 UV5 CliO ++ + yes 
VH-1 V79 
3 UV24 CHO ++ + yes 
27-1 
4 I.N41 CHO ++ +++ yes 
5 UV135 CHO +(+) 4. yes 
6 UV61 CHO + + partially 
7 VBI 1 W9 + 4- partially 
8 US31 Mouse lymphoma + + 
9 CHO4FV ClIO + + partially 
I0 CHO7PV CHO + + partially 




yes  XP-G 
yes CS-B 
aThe number of plus signs indicates thesensitivity of the mutant relative to wild-tylx~ cells: +, 2-5 times greater; +% 5-10 
times greater; +++, more than 10 times greamt than wild-type sensitivity. 
cancer associated with XP-C, and the lower risk for CS. 
As mentioned above, XP-D is a very heterogeneous 
group that includes XP, XP/CS and PIBIDS patients 12. 
NER is least affected in XP-E. Finally, repair in the mild 
XP group F appears to be slow, but ultimately quite 
complete. 
In all XP complementation groups, the defects in 
repair of CPD lesions can be bypassed by introducing 
the prokaryotic CPD-specific endonucleases of bac- 
teriophage T4 and Mfcrococcus iuteus (Ref. 15, and 
references therein). Apparently, when incision of the 
damaged strand has been carried out by exogenous 
enzymes, the cellular repair machinery is capable of 
completing the task. This suggests - but does not 
necessarily prove - that all XP defects reside in NER 
steps preceding incision or affecting incision itself, 
and implies that the first stage of the reaction is quite 
complex. 
Rodent ~ mutants 
A second important category of mammalian 
mutants are the laboratory-induced, UV-sensitive 
rodent cell lines. These are mainly derived from 
Chinese hamster ovary (CHO) cell lines, and there are 
currently 11 NER complementation groups in this class 
of mutants 16. Their main features are summarized in 
Table 2 (reviewed in Ref. 17). Mutants that belong to 
the first five groups are extremely sensitive to UV and 
bulky adducts and in that respect resemble the XP 
groups A, B, D and G. Repair in the few representa- 
tives of the remaining roups appears to be only par- 
tially disturbed, as in CS-A and CS-B and in XP groups 
C, E and F. A unique characteristic of groups 1 and 4 
is their extraordinary sensitivity to cross-linking agents. 
This suggests that the NER genes affected in these 
mutants act in additional systems that repair or 
respond to cross-link damage in DNA. As shown 
below, there is considerable overlap between the 
Chinese hamster mutants and the human NER syn- 
dromes. 
HumanNERgenes 
So far, most mammalian NER genes have been 
isolated by transfection of genomic DNA into IN- 
sensitive rodent repair mutants m, followed by selection 
of IN-resistant transformants and retrieval of the 
correcting sequence. Recendy, however, the use of 
eDNA expression libraries in extrachromosomally 
replicating vectors based on the Epstein-Barr virus t9 
has circumvented many of the problems that previously 
limited the use of human cells for transfection. 
The human genes correcting rodent repair defects 
are called ERCC genes, for excision repair cross- 
complementing rodent repair deficiency genes. The 
number refers to the rodent group that is corrected. 
Table 3 lists the human NER genes cloned thus far 
and summarizes their main properties (reviewed in 
Ref. 20). Some general aspects are discussed below. 
Expresaon 
The cloned mammalian NER genes are weakly and 
constitutively expressed in various cells and tissues. 
No significant IN-inducibility has been observed for 
XPA¢, ERCC1 and ERCC3. 
Overlap between human repair syndromes and rodent 
mutants 
Introduction of the ERCC2, ERCC3 and ERCC6 genes 
into human NER-deficient cell lines alleviated specific 
defects in cells from groups XP-D, XP-B and CS-B 
respectively 21-24. The correspondence b tween ERCC6 
and CS-B identifies ERCC6 as the ~rst eukaryotic NER 
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T~ 3. Properties of  cloned human NER genes 
No. of o~ idenetty/ 
Gene ~mt.o llomolopus slmilarltyto 
Chromosomal size acids In gene In S. ~ Properties 
Gene location O~b) protein .t ¢eret'tv~ gene of protein. 
XPAC 9q34 -25 273 RAD14 27/50 Zn 2* finger 
Binds ss and IN-irradiated sDNA 
XPBCd 2q21 -45 782 RAD25/SSL2 55/72 DNA binding helicase 
ERCC3 Chromatin binding ? 
Role in transcription 
XPCC 823 RALM? Homology to RAD4 limited to one 
segment of the protein 
J¢ PDC/ 19q13.2 -20 760 RAD3 52/72 DNA binding ? 
ERCC2 DNA helicase ? 
Essential function ? 
:.~BCd 10q11-21 -85 1493 unknown DNA helicase 
ERCC6 Chromatin binding ? 
Additional NTP-binding ? 
Nonessential function 
I~CCI 19q13.2 15-17 297 RADIO 26/39 DNA binding ? 
Carboxy terminus has homology to 
segments of UvrA and UvrC. 
Involved in recombination? 
XPGC/ 13q32-33 -32 1186 RAD2 24/39 Complexed with ERCC4, ERCCll, 
ERC¢5 XPFC 
aQuestion marks indicate characteristics inferred on the basis of the predicted amino acid sequences of the proteins. 
protein known to be specifically involved in the 
preferential repair of active genes. The ERCC1 gene did 
not alleviate the NER defect in cell lines of any XP, CS or 
PIBIDS complementation groups (Ref. 25 and our 
unpublished results). Hence ERCC1 is a repair gene not 
yet revealed by the known NER disorders. Recently, he 
ERCC5 and the XPGC (XP-G-correcting) gene products 
were found to be identical26, 2~. Transfection experiments 
have shown that the XP-A-cormcting (XPAC) gene is not 
implicated in rodent groups 1-7 or 11 (our unpublished 
results). It has yet o be established whether XP-C has a 
corresponding rodent mutant. The extensive ovedap be- 
tween human syndromes and rodent mutants tresses 
the value of the latter class for understanding the mol- 
ecular basis of repair defects in humans. 
Overlap between mammalian nd yeast genes 
Except for ERCC6 and possibly XPCC, all human 
genes have identified counterparts in the yeast sys- 
tem 26,~-33 (Table 3), with the level of sequence identity 
between corresponding yeast and mammalian proteins 
ranging from 25% to over 50%. XPCC may be equiv- 
alent to RAD4, but the region of similarity comprises 
only one quarter of the protein 19. Furthermore, the 
NER defects of XP-C (preferential repair unaffected) 
and rad4 (total NER deficiency) appear to differ. The 
ERCC1 gene product shows a remarkable pattern of 
homology with RAD10. The first 214 amino acids align 
with the entire 210 amino acid RAD10 polypeptide29; 
of the remaining 83 residues, the first part shows some 
homology with a segment of the E. coli NER protein 
UvrA, while the 60 carboxy-terminal residues trongly 
resemble the carboxy terminus of UvrC. 
Encoded functions 
XPAC. The purified XPAC protein has an affinity 
for single-stranded (ss) DNA as well as IN-irradiated 
double-stranded ( s) DNA34,3s and contains a predicted 
DNA-binding zinc-finger domain36. Its preference for 
binding to IN-induced lesion# 4 may implicate XPAC 
in damage recognition. From the nature of the XP-A 
repair defect as measured in the in vitro NER assay 
(see below), the protein is expected to function in a 
preincision step of NER (Ref. 37). In a number of XP-A 
patients, the XPAC gene contains aberrant splicing 
signals and nonsense codons, many of which are 
expected to completely inactivate it (Ref. 38 and refer- 
ences therein). In general, there is a good correlation 
between the severity of the mutation and the severity 
of the clinical features. 
XPCC Unfortunately, the predicted 823 amino acid 
sequence of XPCC does not provide interpretable 
clues to its function. The absence of XPCC mRNA in 
many XP-C patients uggests that complete inactivation 
of the gene is not lethal tg. 
ERCC1. Deletion analysis of ERCC1 indicates that 
the five carboxy-terminal mino acids of the protein 
residing in a region that has significant homology with 
the carboxyl terminus of Uvr C, are indispensable for 
its repair function (our unpublished observations). The 
corresponding part of Uvr C is similarly essential39. 
Another parallel between ERCC1 and UvrC is that 
absence of the entire amino-terminal region appears 
not to have a drastic effect on the repair function of 
the proteins. There is recent evidence that ERCC1 
resides in a complex with several other NER proteins: 
the products of the as yet uncloned ERCC4, ERCCll 
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and XPFC genes (our unpublished 
results). Since group 1 and 4 
mutants, unlike other rodent NER 
mutants, are extremely sensitive to 
crosslinking agents, the ERCC1 
complex may also play a role in 
the repair of (a subset of) DNA 
cross links. One of the partners of 
ERCC1 in this complex could be 
the human counterpart of RADI: 
the yeast protein is tightly associ- 
ated with the ERCC1 homologue, 
RADIO (Ref. 1). The role of these 
proteins in mitotic recombination, 
and the presumed ability of RAD1 
to remove regions of non-homol- 
ogy from the 3' end of recombin- 
ing DNA molecules t, are compati- 
ble with the idea that this complex 
may be responsible for, or associ- 
ated with, incision, and (when 
required for the elimination of 
interstrand cross links) with an 
additional recombination step. 
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FIGm 
Comparison ofthe ERCC2/RAD3 and XPBC/ERCC3 proteins. Both proteins are 
schematically represented with the predicted functional domains shown as black boxes. 
Motifs I and VI comprise seven consecutive s quence elements hat match domains 
conserved between superfamilies of DNA and RNA helicases. The scale corresponds to 
the number of amino acids in the protein. NLS, nuclear location signal. 
ERCC2 and ERCC3. The primary amino acid se- 
quences of ERCC2 and ERCC3 suggest hat they are 
helicases23,30. Helicases are known to operate in a 
wide variety of cellular processes including replication, 
recombination, transcription, splicing and translation 
(reviewed in Ref. 40). Two helicases have already 
been demonstrated in the E. coil NER reaction: the 
UvrA2B complex involved in scanning for lesions and 
possibly in attachment of UvrB at the site of the dam- 
age, and UvrD, involved in releasing the damaged 
oligonucleotide after incision I. ERCC2 and ERCC3 
could play similar roles in mammalian NER, or could 
even function in steps that do not exist, or have not 
been discovered, in E. coli. It is interesting to note that 
there are intriguing parallels between ERCC2 and 
ERCC3 (Ref. 23): 
(1) ERCC2 and ERCC3 mutants are very similar; 
(2) The proteins have a similar degree of sequence 
conservation with their yeast cognates RAD3 and 
RAD25/SSL2 (Refs 30-32). 
(3) The proteins are of similar size and their seven 
'helicase' motifs suggest a DNA-unwinding function 
(Fig. 2). Very recently, evidence for helicase activity of 
ERCC3 has been obtained 41. The ERC~'3 gene product 
was identified by Egly and co-workers 4]as one of the 
components of the human TFIIH/BTF2 transcription 
factor, which is required for initiation of transcription 
of genes by RNA polymerase II. Highly purified frac- 
tions of TFIIH have an ATP-dependent helicase activity 
strongly associated with the ERCC3 subunit of the com- 
plex 4]. Other evidence for a role for ERCC3 in gene 
expression has come from the yeast gene RAD25/SSL2 
(Ref. 1) and from the work of Mounkes et aL 4z, who 
have identified the Drosophila homologue of ERCC3 as 
the gene mutated in haywire mutants. These mutants 
show various defects including male-sterility, which is 
thought o be caused by reduced expression of the B2t 
tubulin gene required for normal spermatogenesis 42. 
A role for ERCC3 in transcription (and subtle 
defects in this process caused by mild mutations in the 
gene) may explain some of the clinical symptoms of 
XP-B that are not easily accounted for by the NER 
defect. These include the severe growth defect and the 
dysmyelination of neurons. The latter phenotype may 
be related to the expression level of the myelin basic 
protein that, at least in mice, critically determines the 
degree of CNS myelination 43. This suggests that defects 
in group XP-B represent, at least in part, a transcrip- 
tion syndrome. 
An important question remains: how can ERCC3 
be involved in both transcription and nucleotide x- 
cision? Two options can be envisaged. The simplest 
interpretation is that ERC.~3 catalyses a DNA unwind- 
ing step both in transcription i itiation and in NER. A 
second possibility is that ERCC3 functions only in tran- 
scription initiation, and that some mutations in the 
protein have an adverse ffect on the transcription of 
one or more DNA repair genes, indirectly resulting in 
a NER defect3t. One would then have to assume that 
the strict dependence of such a repair gene on optimal 
functioning of ERCC3 has been preserved in eukary- 
otic evolution from yeast o Drosophila nd to humans. 
Considering the remarkable similarities between 
ERCC2 and ERCC3, it is tempting to speculate that 
these proteins act together in the same step of tran- 
scription initiation and the NER reaction, perhaps 
forming a helicase complex required for local melting 
of the double helix, to allow entry of RNA polymerase 
or NER proteins, and/or their translocation along the 
DNA template z*. Evidence that supports the latter func- 
tion for RAD3 has been reported recently ~. As 
schematically depicted in Fig. 3, the XPAC protein 
and/or the protein mutated in XP-E (Ref. 45) might 
also constitute part of such a complex. It is also poss- 
ible that ERCC2 and ERCC3 are required for release of 
the damage-containing oligonucleotide after incision, 
and turnover of bound NER proteins. 
ERCC5. Homology searches of the 1186 amino acid 
ERCC5 (XPGC) sequence revealed an overall similarity 
with the RAD2 protein. In addition, two regions of 
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FIG[] 
Speculative model for the concerted action of the presumed ERCC2 and ERCC3 helicases 
and the postulated damage recognition protein XPAC in scanning DNA for structural 
distortions. The XP-E protein might also participate in this complex, as it also has 
damage-specific DNA binding activity 4s. 
100 and 140 amino acid residues showed a high 
degree of homology with an open reading frame on 
chromosome XI of S. cerevisiae, the function of which 
is not known 26,27. Unfortunately, the primary 
sequences of these RAD2 family members yield few 
clues to their possible function in NER. 
ERCC6. The predicted sequence of the 1493 amino 
acid protein ERCC6, which belongs to the RAD16 sub- 
family, again reveals putative helic.lse domains z'~. The 
anticipated nucleic acid unwinding activity of ERCC6 
should fit into the mechanism of 'he strand-selective 
repair of active genes that is defective in CS-B. At least 
two possibilities (or a combination of these) can be 
envisaged. First, the protein may be involved in scan- 
ning the transcribed strand ['or a blocked RNA polym- 
erase, thus guiding the NER machinery to lesions 
that thwart transcription. Second, the DNA or 
DNA/RNA unwinding activity may be involved in 
unwinding the RNA-DNA duplex closely behind the 
transcription complex, thus dtssociating it from the 
template and removing steric hindrance to the lesion. 
These speculative models can be tested by biochemical 
experiments using the purified proteins and a bona 
fide in vitro repair assay system. 
Mammalian NER in vilro 
An in vitro NER assay using cell-free extracts 
promises to help resolve the reaction mechanism of 
mammalian NER (Refs 46, 47). This system permits the 
use of defined, damaged DNA substrates and purified 
proteins or antibodies to dissect the reaction into 
discrete steps and to determine the components 
involved. Fractionation of cell extracts has revealed 
that many factors, including the XP-A protein and 
human single-stranded binding protein (HSSB), are 
required for the generation of incised intermediates37. 
Recent analysis of the products of incision has 
demonstrated that, as in E. coil, an asymmetric dual 
incision is made in a damaged template 4s. The 5' inci- 
sion in human NER is made further upstream, and 
one or two nucleotides more 3' of the injury than in 
E. coli, generating a 29 bp lesion- 
containing oligonucleotide ~s. After 
incision, DNA synthesis is appar- 
ently carried out by DNA poly- 
merase 8 or e, since this reaction 
is dependent on the proliferating 
cell nuclear antigen 37 (PCNA). 
DNA polymerase 8 is normally 
implicated in leading strand syn- 
thesis of semi-conservative DNA 
replication. These findings there- 
fore reveal that part of the repli- 
cation machinery, is also used in 
repair reactions, and illustrate that 
there is considerable overlap 
between these fundamental pro- 
cesses that metabolize DNA. 
Concluding remarks 
The known or postulated prop- 
erties of the eukaryotic NER genes, 
and analogy with the main steps of 
the E. coli pathway, suggest the 
following scenario for NER in mammals: 
(1) The ERCC2/ERCC3/XPAC and possibly XPEC 
proteins are involved in detection of lesions, with the 
helicases scanning the DNA helix, and XPAC and 
XPEC recognizing the lesion. ERCC2 may also be 
implicated in this step. 
(2) Upon encountering a lesion, the complex locally 
denatures the DNA; this specific denatured confor- 
mation is recognized by the ERCC1/ERCC4/ERCCll/ 
XPFC complex, which performs the dual incision. The 
Uvr C-like carboxy terminus of ERCC1 could play an 
important role in this reaction. 
(3) HSSB, PCNA and DNA polymerase are involved 
in removal of the damage-containing oligonucleotide, 
turn over of the incision complex and resynthesis of 
DNA. 
Future research will undoubtedly reveal whether this 
speculative scenario bears any relation to the actual situ- 
ation within the cell. Although complete lucidation of 
the eukaryotic NER reaction mechanism ay still seem 
far away, the contours of the systems are beginning to 
emerge from the pieces of the puzzle that have already 
been identified; the yeast model is expected to be of 
great importance because of its versatility and relative 
simplicity. Furthermore, valuable tools are available in 
the form of in vitro repair assay systems. 
Finally, we should soon see the NER genes that 
have already been cloned being used to generate 
repair-deficient mnsgenic mice by targeted gene 
inactivation. Such mouse models may yield valuable 
insight into how the molecular defect is translated into 
clinical features, such as predisposition to cancer, and 
into the origin of the clinical heterogeneity observed in 
human disorders. They may also prove very important 
for studies related to ageing, neurodegeneration a d 
assessment of the genotoxicity of mutagenic agents. 
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